GoAI
Get started
Niagen Bioscience Inc logo

Niagen Bioscience Inc

NAGE

NASDAQHealthcareBiotechnology

Open in GoAI

Previous close

$3.21

+$0.06 · +1.90%

Aug 21, 4:00 PM ET

NAGE company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

91

Deep Value

Momentum

20

Strong Down

Sentiment

65

Bullish

Risk resilience

29

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus on promoting healthy aging. This company is also renowned for its pioneering research into nicotinamide adenine dinucleotide.

Industry
Biotechnology
Sector
Healthcare
Headquarters
US
CEO
Robert N. Fried
Listed since
Jun 24, 2015
Employees
117

Market position

Day range

Current $3.21

52-week range

Current $3.21

Open
$3.215
Previous close
$3.15
Volume
370.32K
0.46× average
Average volume
808.56K
Average daily volume
Market cap
255.66M USD
Beta
2.09
Market reference 1
50-day average
$3.3032
-2.82% below average
200-day average
$4.8488
-33.80% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
441.6M USD
EV / EBITDA
22.48×
Earnings yield
3.45%
Free cash flow yield
2.61%

Profitability & efficiency

Return on equity
22.71%
Return on assets
16.34%
Return on invested capital
15.61%

Financial health

Current ratio
4.86×
Altman Z-score
6.97
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends75%33%-9%-51%Gross margin, FY2021: 61.51%Gross margin, FY2022: 59.40%Gross margin, FY2023: 60.76%Gross margin, FY2024: 61.84%Gross margin, FY2025: 64.28%Operating margin, FY2021: -40.14%Operating margin, FY2022: -25.85%Operating margin, FY2023: -6.70%Operating margin, FY2024: 7.76%Operating margin, FY2025: 11.05%Net margin, FY2021: -40.22%Net margin, FY2022: -22.96%Net margin, FY2023: -5.91%Net margin, FY2024: 8.58%Net margin, FY2025: 13.43%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 61.51%. Gross margin FY2022 59.40%. Gross margin FY2023 60.76%. Gross margin FY2024 61.84%. Gross margin FY2025 64.28%. Operating margin FY2021 -40.14%. Operating margin FY2022 -25.85%. Operating margin FY2023 -6.70%. Operating margin FY2024 7.76%. Operating margin FY2025 11.05%. Net margin FY2021 -40.22%. Net margin FY2022 -22.96%. Net margin FY2023 -5.91%. Net margin FY2024 8.58%. Net margin FY2025 13.43%.

Income trends

Revenue

129.42M USD+29.95%

Operating income

14.3M USD+85.04%

Net income

17.38M USD+103.30%
Income trends across reported periods145.08M USD82.46M USD19.84M USD−42.78M USDRevenue, FY2021: 67.45M USDRevenue, FY2022: 72.05M USDRevenue, FY2023: 83.57M USDRevenue, FY2024: 99.6M USDRevenue, FY2025: 129.42M USDOperating income, FY2021: −27.07M USDOperating income, FY2022: −18.63M USDOperating income, FY2023: −5.6M USDOperating income, FY2024: 7.73M USDOperating income, FY2025: 14.3M USDNet income, FY2021: −27.13M USDNet income, FY2022: −16.54M USDNet income, FY2023: −4.94M USDNet income, FY2024: 8.55M USDNet income, FY2025: 17.38M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 67.45M USD. Revenue FY2022 72.05M USD. Revenue FY2023 83.57M USD. Revenue FY2024 99.6M USD. Revenue FY2025 129.42M USD. Operating income FY2021 −27.07M USD. Operating income FY2022 −18.63M USD. Operating income FY2023 −5.6M USD. Operating income FY2024 7.73M USD. Operating income FY2025 14.3M USD. Net income FY2021 −27.13M USD. Net income FY2022 −16.54M USD. Net income FY2023 −4.94M USD. Net income FY2024 8.55M USD. Net income FY2025 17.38M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue129.42M USD99.6M USD83.57M USD72.05M USD67.45M USD
Cost of goods sold46.23M USD38.01M USD32.79M USD29.25M USD25.96M USD
Gross profit83.19M USD61.59M USD50.78M USD42.8M USD41.49M USD
Research and development6.33M USD6.02M USD4.96M USD4.83M USD3.83M USD
Selling, general, and administrative62.56M USD47.84M USD51.42M USD56.6M USD64.73M USD
Operating expenses68.89M USD53.86M USD56.38M USD61.43M USD68.56M USD
Interest income2.13M USD1.13M USD661K USD3K USD—
Interest expense————55K USD
Depreciation and amortization1.45M USD1.48M USD1.71M USD1.88M USD1.63M USD
Operating income14.3M USD7.73M USD−5.6M USD−18.63M USD−27.07M USD
Net income17.38M USD8.55M USD−4.94M USD−16.54M USD−27.13M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
100%
11 beats, 0 misses, 0 met estimates
Average EPS surprise
+135.35%
11 comparable reports
Latest EPS result
0.01
Estimate 0.01 · Beat by 20.05%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.130.090.050.01Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 4, 2025: actual 0.09, estimate 0.023, surprise +300.00%, Beat. Q2 2025, reported May 7, 2025: actual 0.04, estimate 0.02, surprise +100.00%, Beat. Q3 2025, reported Aug 6, 2025: actual 0.04, estimate 0.02, surprise +100.00%, Beat. Q4 2025, reported Nov 4, 2025: actual 0.05, estimate 0.015, surprise +233.33%, Beat. Q1 2026, reported Mar 4, 2026: actual 0.03, estimate 0.02, surprise +50.00%, Beat. Q2 2026, reported May 6, 2026: actual 0.07, estimate 0.06, surprise +16.67%, Beat. Q3 2026, reported Aug 4, 2026: actual 0.01, estimate 0.008, surprise +20.05%, Beat. Q4 2026, reported Nov 3, 2026: actual —, estimate 0.01, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates35.82M32.35M28.87M25.4MQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Mar 4, 2025: actual 29.13M USD, estimate 26.78M USD, surprise +8.78%, Beat. Q2 2025, reported May 7, 2025: actual 30.48M USD, estimate 27.08M USD, surprise +12.58%, Beat. Q3 2025, reported Aug 6, 2025: actual 31.12M USD, estimate 28.31M USD, surprise +9.92%, Beat. Q4 2025, reported Nov 4, 2025: actual 33.99M USD, estimate 31.1M USD, surprise +9.27%, Beat. Q1 2026, reported Mar 4, 2026: actual 33.84M USD, estimate 31.7M USD, surprise +6.74%, Beat. Q2 2026, reported May 6, 2026: actual 31.47M USD, estimate 31.03M USD, surprise +1.43%, Beat. Q3 2026, reported Aug 4, 2026: actual 29.79M USD, estimate 30.53M USD, surprise -2.45%, Miss. Q4 2026, reported Nov 3, 2026: actual —, estimate 34.45M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

5 ratings
Strong buy00%
Buy5100%
Hold00%
Sell00%
Strong sell00%

Corporate actions

Corporate action history

Stock split

Effective Apr 13, 2016

1:3

NAGE peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding NAGE

Funds reporting this stock among their holdings, ordered by reported position size.

Gabelli Love Our Planet & People ETF logoGabelli Love Our Planet & People ETFLOPP
Market value
9.8M
Weight
0.54%
AUM
18.1M USD
Expense ratio
0.90%
Price / 1D
$37.62+0.55%
Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
5M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
2.24M
Weight
0.00%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
Vanguard Consumer Staples ETF logoVanguard Consumer Staples ETFVDC
Market value
2.03M
Weight
0.02%
AUM
9.3B USD
Expense ratio
0.09%
Price / 1D
$231.75+0.67%
Vanguard Russell 2000 ETF logoVanguard Russell 2000 ETFVTWO
Market value
1.1M
Weight
0.01%
AUM
17.4B USD
Expense ratio
0.06%
Price / 1D
$121.25+0.74%
Schwab U.S. Small-Cap ETF logoSchwab U.S. Small-Cap ETFSCHA
Market value
846.83K
Weight
0.00%
AUM
23.1B USD
Expense ratio
0.03%
Price / 1D
$34.83+0.52%
Amplify Etho Climate Leadership U.S. ETF logoAmplify Etho Climate Leadership U.S. ETFETHO
Market value
405.71K
Weight
0.21%
AUM
197.68M USD
Expense ratio
0.45%
Price / 1D
$82.25+0.66%
Vanguard Russell 2000 Growth ETF logoVanguard Russell 2000 Growth ETFVTWG
Market value
209.7K
Weight
0.01%
AUM
1.7B USD
Expense ratio
0.06%
Price / 1D
$282.73+1.21%

Continue in GoAI

Research NAGE

research.disclaimer